Literature DB >> 33531626

The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2.

Chunjie Meng1, Jun Zhan2, Delin Chen3, Genze Shao4, Hongquan Zhang2, Wei Gu3, Jianyuan Luo5.   

Abstract

The transcription factor nuclear factor (erythroid-derived 2)-like 2 (NRF2) plays a key role in cancer progression and is tightly regulated by the proteasome pathway. E3 ligases that mediate NRF2 ubiquitination have been widely reported, but the mechanism of NRF2 deubiquitination remains largely unclear. Here, we identified ubiquitin-specific-processing protease 11 (USP11) in NRF2 complexes and confirmed an interaction between these two proteins. We further found that USP11 deubiquitinates NRF2; this modification stabilizes NRF2. Functionally, USP11 depletion contributes to the suppression of cell proliferation and induction of ferroptotic cell death due to ROS-mediated stress, which can be largely abrogated by overexpression of NRF2. Finally, immunohistochemical staining of USP11 and NRF2 was performed using a lung tissue microarray, which revealed that USP11 is highly expressed in patients with NSCLC and positively correlated with NRF2 expression. Together, USP11 stabilizes NRF2 and is thus an important player in cell proliferation and ferroptosis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33531626     DOI: 10.1038/s41388-021-01660-5

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

Review 1.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

2.  Oncogenic KRAS confers chemoresistance by upregulating NRF2.

Authors:  Shasha Tao; Shue Wang; Seyed Javad Moghaddam; Aikseng Ooi; Eli Chapman; Pak K Wong; Donna D Zhang
Journal:  Cancer Res       Date:  2014-10-22       Impact factor: 12.701

Review 3.  Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.

Authors:  Xupeng Bai; Yibei Chen; Xiangyu Hou; Min Huang; Jing Jin
Journal:  Drug Metab Rev       Date:  2016-06-20       Impact factor: 4.518

4.  Nrf2 facilitates repair of radiation induced DNA damage through homologous recombination repair pathway in a ROS independent manner in cancer cells.

Authors:  Sundarraj Jayakumar; Debojyoti Pal; Santosh K Sandur
Journal:  Mutat Res       Date:  2015-06-22       Impact factor: 2.433

Review 5.  p62 links autophagy and Nrf2 signaling.

Authors:  Tao Jiang; Bryan Harder; Montserrat Rojo de la Vega; Pak K Wong; Eli Chapman; Donna D Zhang
Journal:  Free Radic Biol Med       Date:  2015-06-24       Impact factor: 7.376

6.  Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming.

Authors:  Yoichiro Mitsuishi; Keiko Taguchi; Yukie Kawatani; Tatsuhiro Shibata; Toshihiro Nukiwa; Hiroyuki Aburatani; Masayuki Yamamoto; Hozumi Motohashi
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

7.  BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis.

Authors:  Clotilde Wiel; Kristell Le Gal; Mohamed X Ibrahim; Chowdhury Arif Jahangir; Muhammad Kashif; Haidong Yao; Dorian V Ziegler; Xiufeng Xu; Tanushree Ghosh; Tanmoy Mondal; Chandrasekhar Kanduri; Per Lindahl; Volkan I Sayin; Martin O Bergo
Journal:  Cell       Date:  2019-06-27       Impact factor: 41.582

8.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.

Authors:  Xiao-Jun Wang; Zheng Sun; Nicole F Villeneuve; Shirley Zhang; Fei Zhao; Yanjie Li; Weimin Chen; Xiaofang Yi; Wenxin Zheng; Georg T Wondrak; Pak Kin Wong; Donna D Zhang
Journal:  Carcinogenesis       Date:  2008-04-15       Impact factor: 4.944

9.  NRF2 regulates serine biosynthesis in non-small cell lung cancer.

Authors:  Gina M DeNicola; Pei-Hsuan Chen; Edouard Mullarky; Jessica A Sudderth; Zeping Hu; David Wu; Hao Tang; Yang Xie; John M Asara; Kenneth E Huffman; Ignacio I Wistuba; John D Minna; Ralph J DeBerardinis; Lewis C Cantley
Journal:  Nat Genet       Date:  2015-10-19       Impact factor: 38.330

10.  Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription.

Authors:  Eri H Kobayashi; Takafumi Suzuki; Ryo Funayama; Takeshi Nagashima; Makiko Hayashi; Hiroki Sekine; Nobuyuki Tanaka; Takashi Moriguchi; Hozumi Motohashi; Keiko Nakayama; Masayuki Yamamoto
Journal:  Nat Commun       Date:  2016-05-23       Impact factor: 14.919

View more
  6 in total

Review 1.  The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis.

Authors:  Yixuan Zhang; Mingrui Li; Yiming Guo; Shuang Liu; Yongguang Tao
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

2.  USP11 regulates autophagy-dependent ferroptosis after spinal cord ischemia-reperfusion injury by deubiquitinating Beclin 1.

Authors:  Yuluo Rong; Jin Fan; Chengyue Ji; Zhuanghui Wang; Xuhui Ge; Jiaxing Wang; Wu Ye; Guoyong Yin; Weihua Cai; Wei Liu
Journal:  Cell Death Differ       Date:  2021-11-27       Impact factor: 12.067

Review 3.  Ferroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities.

Authors:  Peyman Tabnak; Zanyar HajiEsmailPoor; Soroush Soraneh
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

Review 4.  Ferroptosis: Redox Imbalance and Hematological Tumorigenesis.

Authors:  Hongying Lan; Yu Gao; Zhengyang Zhao; Ziqing Mei; Feng Wang
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

Review 5.  Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer.

Authors:  Yu Meng; Huiyan Sun; Yayun Li; Shuang Zhao; Juan Su; Furong Zeng; Guangtong Deng; Xiang Chen
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

6.  Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma.

Authors:  Zhiyuan Shi; Jianzhong Zheng; Qing Liang; Yankuo Liu; Yi Yang; Rui Wang; Mingshan Wang; Qian Zhang; Zuodong Xuan; Huimin Sun; Kejia Wang; Chen Shao
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.